Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review
Authors
Keywords
Immune checkpoint inhibitor, Programed cell death-1, Cytotoxic T lymphocyte antigen 4, Autoreactive T cell, Myositis
Journal
Current Rheumatology Reports
Volume 21, Issue 4, Pages -
Publisher
Springer Nature
Online
2019-02-21
DOI
10.1007/s11926-019-0811-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease
- (2018) François-Xavier Danlos et al. EUROPEAN JOURNAL OF CANCER
- Inflammatory Myopathy and Axonal Neuropathy in a Patient With Melanoma Following Pembrolizumab Treatment
- (2017) Panagiotis T. Diamantopoulos et al. JOURNAL OF IMMUNOTHERAPY
- New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanoma
- (2017) Juliane Behling et al. MELANOMA RESEARCH
- Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies
- (2017) David J. Byun et al. Nature Reviews Endocrinology
- Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review
- (2017) Bum Jun Kim et al. Oncotarget
- Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma
- (2016) H. Vallet et al. ANNALS OF ONCOLOGY
- Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm
- (2016) C.L. Haddox et al. ANNALS OF ONCOLOGY
- Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
- (2016) A. M. Menzies et al. ANNALS OF ONCOLOGY
- Myasthenic crisis and polymyositis induced by one dose of nivolumab
- (2016) Toshihiro Kimura et al. CANCER SCIENCE
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Case of Nivolumab-Induced Myositis
- (2016) E. Fox et al. ONCOLOGIST
- Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
- (2016) Douglas B. Johnson et al. JAMA Oncology
- Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody
- (2016) Mehmet Asim Bilen et al. Journal for ImmunoTherapy of Cancer
- Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis/dermatomyositis
- (2015) Zhiyong Chen et al. CLINICAL RHEUMATOLOGY
- An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
- (2015) Aryeh Fischer et al. EUROPEAN RESPIRATORY JOURNAL
- Case of respiratory discomfort due to myositis after administration of nivolumab
- (2015) Miri Yoshioka et al. JOURNAL OF DERMATOLOGY
- Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy
- (2015) Mizuki Nishino et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Associated Dermatomyositis Following Ipilimumab Therapy
- (2015) Shirwa Sheik Ali et al. JAMA Dermatology
- Autoimmune Inflammatory Myopathy after Treatment with Ipilimumab
- (2014) Gary Hunter et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma
- (2014) B. Liao et al. NEURO-ONCOLOGY
- The Multicenter Study of a New Assay for Simultaneous Detection of Multiple Anti-Aminoacyl-tRNA Synthetases in Myositis and Interstitial Pneumonia
- (2014) Ran Nakashima et al. PLoS One
- Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins
- (2011) Manabu Fujimoto et al. ARTHRITIS AND RHEUMATISM
- Pathophysiology of inflammatory and autoimmune myopathies
- (2011) Marinos C. Dalakas PRESSE MEDICALE
- Paraneoplastic myopathy
- (2009) Katalin Dankó et al. CURRENT OPINION IN RHEUMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now